Arcturus Therapeutics Holdings (ARCT)
(Delayed Data from NSDQ)
$20.61 USD
-0.41 (-1.95%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $20.63 +0.02 (0.10%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth C Momentum A VGM
Arcturus Therapeutics (ARCT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$73.71 | $140.00 | $48.00 | 250.67% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Arcturus Therapeutics comes to $73.71. The forecasts range from a low of $48.00 to a high of $140.00. The average price target represents an increase of 250.67% from the last closing price of $21.02.
Analyst Price Targets (7 )
Broker Rating
Arcturus Therapeutics currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 1.40 a month ago based on 10 recommendations.
Of the nine recommendations deriving the current ABR, nine are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 90%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 9 | 9 | 9 | 8 | 8 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 1 | 1 | 1 |
ABR | 1.00 | 1.00 | 1.40 | 1.44 | 1.44 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/12/2024 | SVB Securities | Lili Nsongo | Not Available | Strong Buy |
8/6/2024 | Cantor Fitzgerald & Co | Pete Stavropoulos | Strong Buy | Strong Buy |
7/2/2024 | H.C. Wainwright & Co. | Ed Arce | Strong Buy | Strong Buy |
5/8/2024 | Piper Sandler | Yasmeen Rahimi | Strong Buy | Strong Buy |
3/11/2024 | Canaccord Genuity | Whitney Ijem | Strong Buy | Strong Buy |
3/8/2024 | Wells Fargo Securities | Yanan Zhu | Strong Buy | Strong Buy |
3/8/2024 | William Blair | Myles R Minter | Strong Buy | Strong Buy |
3/1/2024 | Guggenheim Securities | Seamus Fernandez | Strong Buy | Strong Buy |
2/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 9 |
Average Target Price | $73.71 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | -0.70 |
ARCT FAQs
Arcturus Therapeutics Holdings Inc. (ARCT) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 9 brokerage firms.
The average price target for Arcturus Therapeutics Holdings Inc. (ARCT) is $73.71. The current on short-term price targets is based on 5 reports.
The forecasts for Arcturus Therapeutics Holdings Inc. (ARCT) range from a low of $48 to a high of $140. The average price target represents a increase of $257.64 from the last closing price of $20.61.
The current UPSIDE for Arcturus Therapeutics Holdings Inc. (ARCT) is 257.64%
Based on short-term price targets offered by seven analysts, the average price target for Arcturus Therapeutics comes to $73.71. The forecasts range from a low of $48.00 to a high of $140.00. The average price target represents an increase of 250.67% from the last closing price of $21.02.